Small-molecule generic drugs account for a lion's share of the market, while biosimilars exhibit fastest growth, per a new report from ReasearchAndMarkets.com.
Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia.